Skip to main content
. 2021 Mar 4;16:563–577. doi: 10.2147/COPD.S253770

Figure 3.

Figure 3

CONSORT flow diagram.

Note:aThe n = 100 patients who completed the study also comprised the per-protocol analysis set, which consisted of all patients who met all eligibility criteria and were screened, randomized, and took ≥1 inhalation of study budesonide/formoterol, with ≥60 days of device time on study and without any major protocol deviations.

Abbreviation: CONSORT, Consolidated Standards of Reporting Trials.